Irish Life Investment Managers’s Regeneron Pharmaceuticals REGN Stock Holding History

Irish Life Investment Managers’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$7.35M	Buy	+32,672	New	+$7.61M	0.09%	232

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Irish Life Investment Managers's REGN Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2013: 32,672 shares worth $7.35M. The stake represents 0.09% of the portfolio and ranks #232 among its holdings.

371 funds tracked by Wall St. Rank hold REGN as of Q2 2013.

Irish Life Investment Managers held 32,672 shares of Regeneron Pharmaceuticals worth $7.35M as of Q2 2013.
Regeneron Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
Regeneron Pharmaceuticals made up 0.09% of Irish Life Investment Managers's portfolio in Q2 2013, its #232 holding.
371 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.